Aprea Therapeutics, Inc. (APRE): DEFA14A filed Apr 30, 2026

Form type

DEFA14A

Filing date

Apr 30, 2026

Accession number

0001104659-26-052049

Filer

Aprea Therapeutics, Inc. (CIK 1781983)